Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Novavax Missed Q1 Estimates By a Mile: Should Investors Worry?
05:51am, Tuesday, 10'th May 2022
The vaccine maker faces a few big uncertainties.
Stock Market Plunge: 5 Discounted Growth Stocks to Buy Now and Hold Forever
05:06am, Tuesday, 10'th May 2022
These innovative, fast-paced stocks are historically cheap and ripe for the picking by opportunistic investors.
Novavax Stock Tanks as Profit and Sales Badly Trail Estimates
04:23am, Tuesday, 10'th May 2022
The vaccine maker reports its first profitable quarter but the stock sinks after earnings miss Wall Street expectations.
Novavax, Inc. (NVAX) CEO Stan Erck on Q1 2022 Results - Earnings Call Transcript
09:09pm, Monday, 09'th May 2022
Novavax, Inc. (NASDAQ:NVAX ) Q1 2022 Results Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Silvia Taylor - SVP, Global Corporate Affairs & IR Stan Erck - President, CEO John Tri
Novavax Stock Is Too Sickly To Buy
07:15pm, Monday, 09'th May 2022
Any hope that pharmaceutical company Novavax will gain widespread approval to bring a Covid-19 vaccine to market is now over. The post Novavax Stock Is Too Sickly To Buy appeared first on InvestorPlac
Novavax: Avoid This Cancer At All Costs
05:14pm, Monday, 09'th May 2022
We expect NVAX's FQ1'22 earnings call to be disappointing, given its minimal deliveries in the quarter. As usual, the management had overpromised and underdelivered. Again.
Why Novavax Shares Are Falling After Hours
04:30pm, Monday, 09'th May 2022
Novavax Inc (NASDAQ: NVAX) shares are trading lower in Monday's after-hours session after the company reported worse-than-expected financial results. Novavax reported first-quarter revenue of $704 mi
Novavax posts first profitable quarter as Covid vaccine rolls out around the world
04:13pm, Monday, 09'th May 2022
Novavax reported net income of $203 million in the first quarter, compared to a net loss of $222.7 million the same period last year.
How Novavax Stock Looks Headed Into Q1 Earnings
03:58pm, Monday, 09'th May 2022
Novavax, Inc. (NASDAQ: NVAX) is set to print its first-quarter financial results after the market close on Thursday. The stock was trading more than 6% lower, at one point, heading into the event.
Best Stocks To Buy Now? 5 Health Care Stocks In Focus
02:30pm, Monday, 09'th May 2022
Could these health care stocks be the remedy to investors' recent stock market pains?
Could Novavax Stock Help You Retire a Millionaire?
07:05am, Monday, 09'th May 2022
This biotech company isn't just a COVID-19 play.
Palantir, Plug Power, Novavax, BioNTech, Lordstown: 5 Key Earnings To Watch Today
05:23am, Monday, 09'th May 2022
The first-quarter reporting season is well and truly underway. Data from Factset show that about 87% of S&P 500 companies have reported their quarterly results, with 79% reporting positive earning
Is a Surprise Coming for Novavax (NVAX) This Earnings Season?
10:32am, Friday, 06'th May 2022
Novavax (NVAX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Novavax Is Crushing It This Week
05:50am, Friday, 06'th May 2022
Investors appear to be jumping back on the vaccine maker's bandwagon.
Arvinas, Inc. (ARVN) Reports Q1 Loss, Lags Revenue Estimates
12:15pm, Thursday, 05'th May 2022 Zacks Investment Research
Arvinas, Inc. (ARVN) delivered earnings and revenue surprises of -41.18% and 23.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
